It is noted that nanomedicine has been applied widely in targeting PD-L1 delivery for cancer immunotherapy due to their versatility and tunability, which can efficiently penetrate TME and specifically deliver to the major components in TME 27, 28. The gene discussed is CD274; the disease is cancer.